1. Adams, J., Geis, L., Baral, M., Mitchell, J. I., Hensley, A., Newmark, S., et al. (2008). Results of DMSA treatment study. Presented at the Autism One Conference, Chicago, Illinois.
2. Aman, M. G., Singh, N. N., & Stewart, A. W. (1985). The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 5, 485–491.
3. American Academy of Child & Adolescent Psychiatry. (1999, March 3). Secretin in the treatment of autism [Policy statement]. Retrieved August 6, 2007 from http://www.aacap.org/cs/root/policy_statements/secretin_in_the_treatment_of_autism .
4. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, fourth edition-text revision. Washington, DC: American Psychiatric Association.
5. Amminger, G. P., Berger, G. E., Schafer, M. R., Klier, C., Friedrich, M. H., & Feucht, M. (2007). Omega-3 fatty acids supplementation in children with autism: A double-blind randomized, placebo-controlled study. Biological Psychiatry, 61, 551–553.